66.96
2.03%
-1.39
Handel nachbörslich:
66.94
-0.02
-0.03%
Finanzdaten der Utah Medical Products Inc-Aktie (UTMD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
8.05%
11.34
|
12.33 | 12.51 | 12.87 | 12.52 |
Cost Of Revenue |
12.63%
4.574
|
5.235 | 5.146 | 5.127 | 4.677 |
Gross Profit |
4.68%
6.766
|
7.098 | 7.359 | 7.739 | 7.843 |
Operating Expenses
|
2.56%
2.883
|
2.811 | 3.39 | 3.314 | 3.404 |
Benefits Costs and Expenses |
18.69%
6.542
|
8.046 | 8.57 | 8.666 | 8.306 |
Costs And Expenses |
18.69%
6.542
|
8.046 | 8.57 | 8.666 | 8.306 |
Operating Income/Loss |
9.42%
3.883
|
4.287 | 3.969 | 4.425 | 4.439 |
Income/Loss From Continuing Operations Before Tax |
11.92%
4.798
|
4.287 | 4.781 | 5.172 | 5.119 |
Income Tax Expense/Benefit, Deferred |
53.06%
-0.192
|
-0.409 | -0.147 | -0.134 | -0.003 |
Income Tax Expense/Benefit |
15.18%
0.842
|
0.731 | 0.846 | 0.972 | 0.905 |
Income/Loss From Continuing Operations After Tax |
7.72%
3.956
|
4.287 | 3.935 | 4.20 | 4.214 |
Net Income/Loss
|
7.72%
3.956
|
4.287 | 3.935 | 4.20 | 4.214 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
3.618
|
- | 3.629 | 3.628 | 3.628 |
Diluted Average Shares |
361.90K%
3.618
|
-0.001 | 3.639 | 3.639 | 3.636 |
Basic Earnings Per Share |
7.63%
1.09
|
1.18 | 1.08 | 1.16 | 1.16 |
Diluted Earnings Per Share |
7.63%
1.09
|
1.18 | 1.08 | 1.15 | 1.16 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):